Boston Scientific Corporation (BSX)

Market Cap	131.10B
Revenue (ttm)	15.91B
Net Income (ttm)	1.79B
Shares Out	1.47B
EPS (ttm)	1.21
PE Ratio	73.58
Forward PE	32.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,982,761
Open	88.00
Previous Close	88.66
Day's Range	87.25 - 89.67
52-Week Range	55.60 - 91.93
Beta	0.80
Analysts	Strong Buy
Price Target	96.41 (+8.39%)
Earnings Date	Jan 29, 2025

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, c...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 18, 1992
• Employees: 48,000
• Stock Exchange: NYSE
• Ticker Symbol: BSX
• Website: https://www.bostonscientific.com

Financial Performance

In 2023, Boston Scientific's revenue was $14.24 billion, an increase of 12.29% compared to the previous year's $12.68 billion. Earnings were $1.57 billion, an increase of 144.55%.

Analyst Forecast

According to 23 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is $96.41, which is an increase of 8.39% from the latest price.

Price Target

$96.41

(8.39% upside)

Analyst Consensus: Strong Buy